Medical and Pharmaceutical Industry - Market Research Report

  The global antibody drug conjugates market size was estimated at USD 11.29 billion in 2023 and is projected to grow at a CAGR of 9.2% from 2024 to 2030. This can be attributed to the presence of a robust R&D pipeline. This, coupled with the growing incidence of cancer and increased demand for low-toxicity & effective drugs, is expected to drive market growth. Some of the key Antibody Drug Conjugates (ADCs) currently available in the market are Kadcyla (Genentech/Roche), Adcetris (Seattle Genetics), Enhertu (AstraZeneca/Daiichi Sankyo), Besponsa (Pfizer), Mylotarg (Pfizer), and Polivy (Genentech/Roche). ADCs are a novel category of drugs composed of an antibody linked-via a chemical linker-to a cytotoxic drug.   Conventional chemotherapy is intended to eradicate fast-growing tumor cells. However, it can also damage healthy proliferating cells, which may produce undesirable effects. In contrast, ADC is designed to upsurge the efficacy of treatment and decrease systemic toxicity

 The global endoscopy devices market size is expected to reach USD 76.41 billion by 2030, registering a CAGR of 3.58% from 2024 to 2030, according to a new report by Grand View Research, Inc. Healthcare systems worldwide are increasingly incorporating endoscopic procedures into their cancer management protocols for early detection & treatment of cancer to improve survival rates. This trend and the rising global cancer burden are expected to boost the demand for endoscopes, driving market growth. Moreover, manufacturers in the market are continuously innovating and expanding their endoscope product lines to meet the growing clinical needs, aiming to equip them with the most advanced technology for effective cancer treatment.   The demand for disposable endoscopes is growing due to the rising concerns regarding cross-contamination risks associated with reusable endoscopes. This growing focus on patient safety has increased innovation and regulatory actions aimed at enhancing the av